2016 Shaffer Research Grants

For information about Shaffer Grants and research reports prior to 2013, please contact Glaucoma Research Foundation.

Spacing: small

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013

Spacing: small
Kevin Park

Kevin Park, PhD

University of Miami Miller School of Medicine, Miami, FL
Funded by The Melza M. and Frank Theodore Barr Foundation, Inc.
Project: Axon-astroglial Interaction and its Effects on Optic Nerve Repair
Summary: In glaucoma, the optic nerve which sends visual information from eye to brain gets damaged.
Ian Pitha, Md, Phd

Ian Pitha, MD, PhD

Johns Hopkins University, Wilmer Eye Institute, Baltimore, MD
Funded by Dr. James and Elizabeth Wise
Project: Neuroprotection through Altered Scleral Biomechanics
Summary: To date, the only way to stop vision loss from glaucoma is intraocular pressure (IOP) reduction by daily medication use, laser procedure, or incisional surgery.
Carla J. Siegfried, Md

Carla J. Siegfried, MD

Washington University School of Medicine, St. Louis, MO
Funded by The Alcon Foundation
Project: Pathological Alterations in the Trabecular Meshwork Following Vitrectomy and Lens Extraction: A Model of Oxidative Stress
Summary: Elevation of pressure in the eye is the only risk factor for glaucoma that can be modified.
W. Daniel Stamer, Phd, Farvo

W. Daniel Stamer, PhD, FARVO

Duke University Eye Center, Durham, NC
Funded by The Alcon Foundation
Project: Role of Exosomes in Glaucomatous Lamina Cribrosa Remodeling
Summary: In this project we have optimized techniques to isolate and characterize exosomes from lamina cribrosa cells.
David T. Stark

David T. Stark, MD, PhD

Stein Eye Institute, David Geffen School of Medicine at UCLA, Los Angeles, CA
Funded by The Frank Stein and Paul S. May Grants for Innovative Glaucoma Research
Project: Endocannabinoids in Retinal Ganglion Cell Regeneration
Summary: Many optic nerve diseases result in permanent loss of vision.
Evan B. Stubbs, Jr., Phd

Evan B. Stubbs, Jr., PhD

Edward Hines, Jr. VA Hospital, Hines, IL
Funded by The Alcon Foundation
Project: Mitochondrial-specific Antioxidant XJB-3-151 as a Novel Therapeutic Strategy to Lower Elevated Intraocular Pressure
Summary: Glaucoma is a silent disease that, over time, kills the nerve cells of the retina leading to irreversible blindness.
David A. Sullivan

David A. Sullivan, MS, PhD, FARVO; Co-investigator: Louis R. Pasquale, MD

Schepens Eye Research Institute, Massachusetts Eye and Ear, Harvard Medical School, Boston, MA
Funded by The Dr. Henry A. Sutro Family Grant for Research
Project: Estrogen & Glaucoma
Summary: Glaucoma is characterized by a gradual loss of retinal ganglion cells (RGCs), which leads to a loss of vision.
Frank Talke

Frank Talke, PhD

University of California, San Diego
Funded by The Frank Stein and Paul S. May Grants for Innovative Glaucoma Research
Project: Development of an Optical-based Intraocular Pressure Sensor
Summary: We have developed an intraocular pressure sensor based on the principle of interferometry.